These drugs work by mimicking GLP-1, a naturally occurring hormone made in the intestines
Gradually reintroduce a wider variety of foods as tolerance allows
Xue X, Ren Z, Zhang A, Yang Q, Zhang W, Liu F (2016) Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials
This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal
That makes it cheaper to manufacture and avoids some of the drug interaction concerns
Patients often find they: Naturally choose smaller portions Stop eating when satisfied rather than overly full Snack less between meals Feel more in control around food This makes lifestyle changes easier to maintain over time, rather than feeling like a temporary diet